CAPE CANAVERAL SPACE FORCE STATION — For those who woke up early on Thursday morning, they got to see SpaceX launch AST SpaceMobile’s five commercial satellites despite the weather not looking ...
bluebird bio's Zynteglo has become the first cell-based gene therapy to be approved in the US, getting the nod from the FDA as a treatment for patients with beta thalassaemia who require regular blood ...
The FDA has added a warning label to bluebird bio's Skysona, after launching an investigation into cases of blood cancer in patients treated with the ex vivo gene therapy last November. Skysona ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback